1. Safety and efficacy of apixaban, dabigatran and rivaroxaban in obese and morbidly obese patients with heart failure and atrial fibrillation: A real‐world analysis. Issue 1 (1st December 2022) Authors: Chugh, Yashasvi; Gupta, Kashvi; Krishna, Hanumanthu Balram; Ayala, Renato Quispe; Zepeda, Ignacio; Grushko, Michael; Faillace, Robert T Journal: Pacing and clinical electrophysiology Issue: Volume 46:Issue 1(2023) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗